Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (36547)	4/26/1999 11:46:00 PM
From: kha vu	Read Replies (1) \| Respond to of 120523

LIPO: stock #4 of wl 4/26 will release earnings to morrow morning before the opening of market. I called IR: IR does NOT want to disclose any thing more than that...

To: Jenna who wrote (36547)	4/27/1999 11:28:00 AM
From: Jenna	Respond to of 120523

<ALERT>SDLI reports today confirmed. ADRX +9 1/4, KING up another 2 You have to get used to these drug and biotech companies as earnings plays they fly up very quickly and do very well if you nab them in time. KING is a very quick mover. NXLK, KING, ADRX all called before. techstocks.com techstocks.com techstocks.com Andrx Reports Continued Increase in Profits Good report today, stock was called as triggering a buy yesterday as it was up as 5 intraday and closed up 2. Now up another 9 1/2 points. I was particularly bullish on this company. Another I'm following is CHRX.. that was also on the watch list about a week or so ago. Would have had CHRX as earnings play as well but the company doesn't know when earnings are coming out "in the next 45 days" I know its got a large spread, but for 9 point gain its not so bad. ADRX was a watch list pick before and an earnings play. It was called yesterday as it triggered a buy signal. Earnings out and they were very good. A positive quarter compared to a negative. Company right here in Ft. Lauderdale. FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--April 27, 1999--ANDRX CORPORATION (Nasdaq:ADRX - news) today announced its results for the three months ended March 31, 1999. For the 1999 first quarter, Andrx reported net income of $6,944,000 or $0.43 per diluted share as compared to a net loss of $960,000 or $0.06 per diluted share for the 1998 first quarter. Total revenues increased by 53.7% to $77,924,000 for the 1999 first quarter as compared to $50,695,000 for the 1998 first quarter. For the first quarter of 1999, sales from distributed products increased by 31.1% to $63,025,000 as compared to $48,080,000 for the 1998 first quarter. Sales from manufactured products increased to $4,373,000 for the 1999 first quarter as compared to $2,615,000 for the 1998 first quarter. In the 1999 first quarter, Andrx earned $10,000,000 in stipulation fees under its status quo stipulation and agreement with Hoechst Marion Roussel Inc. and Carderm Capital L.P.